Philip S. Crosier
Papers
2
Total Citations
39
H-Index
2
About
Philip S. Crosier is a pioneering researcher in developmental biology and biomedical engineering, whose work centers on leveraging transgenic zebrafish models to study human disease and drug discovery. His major contributions include the development of innovative, chip-based technologies that enable automated, high-throughput analysis of zebrafish embryos. Notably, his 2014 paper on an integrated chip-based physiometer for automated fish embryo toxicity biotests—cited 32 times—revolutionized pharmaceutical screening and ecotoxicology by allowing precise, scalable immobilization and treatment of embryos. This work bridges molecular pathology and environmental toxicology, offering a powerful tool for assessing drug safety and toxicity. Additionally, his 2013 study on dynamic angiogenesis analysis using a 3D multilayer chip-based technology, while less cited, showcases his commitment to advancing 3D imaging and microfluidics for real-time observation of vascular development. Crosier’s achievements lie in creating automated platforms that replace manual, low-throughput methods, significantly impacting how researchers model human diseases and screen therapeutics. His interdisciplinary approach—combining genetics, engineering, and toxicology—has established him as a key figure in zebrafish-based biomedical research, with his technologies enabling more efficient, ethical, and reproducible studies in drug development and environmental health.
Research Focus
Key Achievements
Top Papers
- 1
- 2